chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 14.0
Sex: F
Vaccine: HEPA, HPV4
Symptoms: Abdominal pain lower, Back pain, Drug exposure during pregnancy, Haemoglobin normal, Pregnancy test positive
Clinical narrative: Information has been received from a registered nurse from health department for the Pregnancy Registry for GARDASIL, concerning a 14 year old female patient with previous back injury and previous "female problems" and scarring, who on 18-NOV-2008 was vaccinated with a 0.5 ml dose of GARDASIL, intramuscularly (lot number unavailable). On 09-FEB-2009 the patient was vaccinated with the second 0.5 ml dose of GARDASIL, intramuscularly (lot number unavailable). On 09-SEP-2009 the patient was vaccinated with the third 0.5 ml dose (lot # 662229/1497X) intramuscularly in the right deltoid by the health department. On the same day, the patient was also vaccinated with a dose of HAVRIX. On 26-SEP-2009 the patient had gone to the emergency room for back and lower abdominal pain and was given a pregnancy test. The emergency room physician determined she was 12 weeks into her pregnancy (LMP: 04-JUL-2009) although the patient reported to the health department that the last menstrual period was 01-AUG-2009. On an unspecified date, a hemoglobin test was performed with a result of 12.5. At the time of reporting, the patient's outcome was unknown. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Back pain
Clinical narrative: Information has been received from a physician concerning a female patient who was vaccinated IM with her first dose of GARDASIL. The patient experienced lower back pain after receiving the vaccination of GARDASIL. The physician did report that the patient was a gymnast. The physician recommended that the patient see a specialist regarding the lower back pain. The outcome of the patient's lower back pain was not reported. Additional information has been requested.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Hypotonia, Pallor
Clinical narrative: Information has been received from a physician concerning a 15 year old female who on 15-SEP-2009 was vaccinated with her first dose of GARDASIL (lot # not provided). The physician stated after receiving the GARDASIL, within 10 minutes the patient was limp and had an ashy, pale color. The patient was monitored in the office for a short period of time and seemed to have fully recovered. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Syncope
Clinical narrative: Information has been received from a nurse practitioner concerning a female patient who in approximately August 2009 (about a month ago) was vaccinated with a dose of GARDASIL IM and fainted. There was no concomitant medication. The patient recovered the same day. The patient sought medical attention by an office visit. Additional information has been requested.
Age: 23.0
Sex: F
Vaccine: HPV4
Symptoms: Pruritus generalised
Clinical narrative: Information has been received from a nurse concerning a 23 year old female patient with no pertinent medical history or drug reactions who on 22-JUL-2009 was vaccinated with the first dose of GARDASIL (lot# not reported). On 28-SEP-2009 the patient received the second dose of GARDASIL (IM, 0.5ml, lot# 663453/0249Y) in her right deltoid. There was no concomitant medication. On 29-SEP-2009 the patient called the doctor office and complained of generalized body itching. The patient did take Antihistamine CLARITIN but it did not alleviate the itching. There was no laboratory diagnostics studies performed. The doctor recommended over the counter BENADRYL. At the reporting time the outcome was unknown. Follow up information has been received from the nurse concerning the 23 year old female student who on 28-SEP-2009, at 14:45, was vaccinated with the second dose of GARDASIL. On 30-SEP-2009, at 10:00, the patient called and stated that she was itching all over the body. She took a CLARITIN that morning and she was told to try BENADRYL. She was told that she would not receive the third dose of GARDASIL. At the time of this report, the patient's outcome was unknown. Follow up information has been received from the nurse concerning the patient who on an unspecified date in October 2009 recovered from symptoms. It was reported that the patient would not receive any more injections. Additional information is not expected.
Sex: F
Vaccine: FLUX, HPV4
Symptoms: Injection site pain, No reaction on previous exposure to drug
Clinical narrative: Information has been received from a nurse concerning a female in her 20's who was vaccinated with the third dose of GARDASIL (lot# not available) on an unspecified date. Concomitant therapy included influenza virus vaccine (unspecified) on the opposite arm. Subsequently the patient experienced pain at the injection site after receiving the vaccine. The patient did not have adverse experience with the 1st and 2nd dose. At the reporting time the patient had not recovered. Additional information has been requested.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Contusion, Skin discolouration
Clinical narrative: Information has been received from a physician assistant concerning a 15 year old female patient who in December 2007, was vaccinated with the first dose of GARDASIL (lot number not reported). The dose was given by another provider at another facility. There was no concomitant medication. '1 week later', approximately in December 2007 the patient had a single bruise on the forehead. On 30-SEP-2009, the patient was seen in the office, it was reported that the bruise was not there but in place of the bruise there was a darkness of the skin and discoloration. The patient did not receive any further doses of the GARDASIL. There were no lab studies performed. Additional information has been requested.
Age: 17.0
Sex: F
Vaccine: HPV4
Symptoms: Drug exposure during pregnancy, Episiotomy, Induced labour, Ultrasound antenatal screen normal
Clinical narrative: Information has been received from a nurse, for GARDASIL, a Pregnancy Registry product, concerning a 17 year old female patient with no pertinent medical history and no known drug allergies who on 29-JUL-2009 was vaccinated IM with a 0.5 ml dose of GARDASIL (lot number 661953/1130X). There was no concomitant medication. The patient was pregnant when received the dose, the last menstrual period (LMP) approximately on 30-MAY-2009. There was no adverse event reported. On an unspecified date the patient saw a doctor. There were no lab studies performed. At the time of the report, the outcome of the patient was not reported. Follow-up information received from the nurse concerning the female with no history of previous pregnancy who on 29-JUL-2009 was vaccinated with a dose of GARDASIL (lot number 661953/1130X). The LMP of the patient was 31-MAR-2009 (previously reported as approximately 30-MAY-2009). On 15-SEP-2009 an ultrasound was performed for no prenatal care, which resulted in live intrauterine. The estimated delivery date is 14-DEC-2009. On 23-DEC-2009 the patient's labor was induced with CERVIDIL for postdate pregnancy. On 24-DEC-2009, 41 weeks and 3 days from the LMP, the patient gave birth to a 7 pounds 15.7 ounces weight normal baby (sex unspecified). The Apgar score was 8 at 1 minute and 9 at 5 minutes. The patient had episiotomy and 3 degree extension during labor/delivery. PITOCIN was used. Additional information is not expected.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Headache, Hearing impaired, Injection site pain, Pain, Pain in extremity
Clinical narrative: Information has been received from a physician concerning a female patient who was vaccinated with a 0.5 mL first dose of GARDASIL, intramuscularly. The patient had a shooting pain that went down her arm, back up around her head and down her other arm and into her legs. It also affected her sight and hearing. The patient did not mention this to her physician until she came back for her second dose. The physician did not administer the second dose. The patient sought unspecified medical attention. At the time of the report, the outcome of the patient was unknown. Follow up information has been received from the licensed practical nurse concerning the 18 year old female patient with no illness at the time of vaccination who on 27-JUL-2009 at 2:35 pm was vaccinated with a first IM dose of GARDASIL (Lot # 0702X) into her left deltoid. It was reported that there was no adverse event. It was also reported that when the patient visited the doctor's office on August 2009 she was OK. Additional information is not expected.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Visual impairment
Clinical narrative: Information has been received from a physician concerning a female patient who was vaccinated with a 0.5 mL first dose of GARDASIL, intramuscularly. The patient had a shooting pain that went down her arm, back up around her head and down her other arm and into her legs. It also affected her sight and hearing. The patient did not mention this to her physician until she came back for her second dose. The physician did not administer the second dose. The patient sought unspecified medical attention. At the time of the report, the outcome of the patient was unknown. Follow up information has been received from the licensed practical nurse concerning the 18 year old female patient with no illness at the time of vaccination who on 27-JUL-2009 at 2:35 pm was vaccinated with a first IM dose of GARDASIL (Lot # 0702X) into her left deltoid. It was reported that there was no adverse event. It was also reported that when the patient visited the doctor's office on August 2009 she was OK. Additional information is not expected.
Sex: F
Vaccine: HPV4
Symptoms: Dizziness, Electrocardiogram normal, Fatigue, Palpitations, Thyroid function test normal
Clinical narrative: Information has been received from a nurse practitioner concerning a female patient with migraine headaches and mild Tourette's disease who was vaccinated with the first dose of GARDASIL at her unspecified gynecologist's office. Concomitant therapy included HALDOL and AVIANE. Subsequently the patient developed intermittent palpitations, fatigue and lightheadedness after the first dose of vaccine. The symptoms worsened and became more persistent after the patient received her second dose of GARDASIL. The dates of administration of the doses, as well as the date of onset of the symptoms, was unknown. The patient was examined in the office on 28-SEP-2009. An EKG and thyroid function tests were normal. A Holter monitor has been scheduled. At the time of reporting, the patient had not recovered. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Hepatic function abnormal
Clinical narrative: Information has been received from a nurse concerning a female patient who was vaccinated with GARDASIL. Subsequently the patient experienced severe liver function problems. The patient had sought unknown medical attention. At the time of report the patient's status was unknown. No further information is available.
Age: 16.0
Sex: F
Vaccine: HPV4
Symptoms: Pain in extremity
Clinical narrative: Information has been received from a consumer concerning her 16 year old daughter with no known drug reactions/allergies or pertinent medical history who on 07-SEP-2009 was vaccinated with a dose of GARDASIL (Lot # not provided). There was no concomitant medication. The consumer stated that after the vaccination, on approximately 14-SEP-2009 the patient experienced leg pain and limbs. The patient has sought medical attention. No laboratory/diagnostic studies were performed. At the time of this report, the patient was not recovered. This is one of two reports received from the same source. No further information is available.
Age: 16.0
Sex: F
Vaccine: HEPA, HPV4
Symptoms: Loss of consciousness
Clinical narrative: Information has been received from a physician concerning a 16 year old female patient with no pertinent medical history who in June 2008, was vaccinated with her first dose of GARDASIL. In July 2009, the patient received her second dose of GARDASIL. Concomitant vaccination in July 2009 included HAVRIX. The reporter stated that two days post vaccination the patient "passed out" while she was at a friend's house. The physician also reported that the patient recovered that day and was doing fine at the time of the report, but the physician did not know if the patient was going to receive the third dose of GARDASIL. The physician stated the patient was not pregnant. The patient sought unspecified medical attention. Additional information has been requested.
Age: 13.0
Sex: F
Vaccine: HPV4
Symptoms: Menorrhagia
Clinical narrative: Information has been received from a medical assistant concerning her 13 year old daughter who on 06-SEP-2009 was vaccinated with her second dose of GARDASIL series. There was no concomitant medication. The reporter stated that "at the time of the vaccination, the patient had her menstrual cycle and after the vaccination, the patient continued to menstruate for the rest of the month when it usually last for 5 days. The patient recovered (date unspecified by reporter) but they did not know if she should receive the third dose". The patient sought unspecified medical attention. Additional information has been requested.
Age: 21.0
Sex: F
Vaccine: FLUX, HPV4
Symptoms: Fall, Loss of consciousness
Clinical narrative: Information has been received from a physician concerning a 19 year old female patient who "last week", on approximately 24-SEP-2009, was vaccinated with her second "standard dose" of GARDASIL. Secondary suspect vaccination on the same day included a dose of influenza virus vaccine (unspecified) (manufacturer unknown). The physician reported that "last week", on approximately 24-SEP-2009, after the patient received the GARDASIL the patient passed out. The patient sought unspecified medical attention. It was noted that the patient recovered the same day of vaccination. Follow up information has been received from the physician regarding the 21 (previously reported as 19) year old female patient with no known drug reactions/allergies or pertinent medical history who on 25-SEP-2009, was vaccinated in the right arm with a dose of GARDASIL. The physician reported that the patient had received the GARDASIL then when she was going to receive a flu shot (walked around the patient), the patient black out, falling to the right off the table. The patient was laid down, within a minute, the patient regained consciousness without nausea or vomiting. The patient was watched for additional 15 minutes and the patient was well. It was noted that the patient did not have any illness at the time of vaccination. On 25-SEP-2009 the patient had recovered. No further information is available.
Sex: F
Vaccine: HPV4, MNQ
Symptoms: Infectious mononucleosis
Clinical narrative: Information has been received from an office manager concerning a female patient who on an unspecified date was vaccinated intramuscularly with the first dose of GARDASIL (Lot number was unknown). Concomitant vaccine therapy included on the same day a dose of MENACTRA. It was reported that shortly after (date not reported) the patient developed mononucleosis. The manager was not sure if the GARDASIL series was completed. It was unknown if the patient sought medical attention. At the time of the report, the outcome of the patient's mononucleosis was unknown. Additional information has been requested.
Age: 19.0
Sex: F
Vaccine: HPV4
Symptoms: Adverse event, Malaise, Syncope, Tremor, Vomiting
Clinical narrative: Information has been received from a consumer concerning her daughter in her "late teens" who on an unspecified date was vaccinated with a dose of GARDASIL. The consumer reported that her daughter became very sick after she received a dose of GARDASIL, she fainted and experienced vomiting and uncontrollable shaking among other unspecified symptoms. At the time of the report, the patient had not recovered. No further information is available.
Sex: F
Vaccine: HPV4
Symptoms: Injection site erythema
Clinical narrative: Information has been received from a patient's mother via Internet concerning her daughter who was vaccinated the past year, in 2008, with a dose of GARDASIL. The patient had no adverse reaction besides the injection site being red for a day. No further information is available.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Blood urine present
Clinical narrative: Information has been received from a female consumer concerning her daughter, an 18 years old female without a pertinent medical history who on 31-AUG-2009 was vaccinated with her first dose of GARDASIL. There was not concomitant medication. The reporter stated that the patient had blood in her urine a month later (approximately on 30-SEP-2009) after receiving the vaccine and that this happened twice but it had not occurred again. It was also reported that on 30-SEP-2009 the patient was due for the second dose of GARDASIL. No laboratory and diagnostic test were performed. The patient did not seek medical attention. This is one of two reports from the same source. Additional information has been requested.
Age: 14.0
Sex: F
Vaccine: HPV4
Symptoms: Breast induration, Breast infection, Breast mass
Clinical narrative: Information has been received from a registered nurse concerning a 14 year old female patient who was vaccinated with her second dose of GARDASIL. Subsequently the patient developed a breast infection. The infection was treated with antibiotics. Her breast became hard with a rash. She still had a lump at the site of the infection. The patient had sought medical attention in office. At the time of reporting, the patient was recovering from the adverse events. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Alopecia, Fatigue, Insomnia
Clinical narrative: Information has been received from a patient's mother via Internet. On an unspecified date, the patient was vaccinated with a dose of GARDASIL. The mother stated that her daughter experienced a great deal of hair loss, trouble sleeping through the night and extreme fatigue. The mother stated that she will not complete the series of GARDASIL. No further information is available.
Age: 16.0
Sex: F
Vaccine: HPV4
Symptoms: Allergy test positive, Biopsy skin, Haematology test abnormal, Hypersensitivity, Lip swelling
Clinical narrative: Information has been received from a consumer concerning her 16 year old daughter with no pertinent medical history who on 21-JUN-2009 was vaccinated with the first dose of GARDASIL (dose, route and LOT# not reported). Concomitant therapy included ZYRTEC and ZANTAC. Four weeks after vaccination, the patient developed hives and her lips and mouth swelled up. The patient was taken to the emergency room. The consumer also reported that her daughter's physician did "bloodwork" and a skin biopsy (results not reported). The "bloodwork" showed that the patient was "allergic to everything now". At the time of the report, the patient had not recovered. No further information is available.
Age: 16.0
Sex: F
Vaccine: HPV4
Symptoms: Oedema mouth, Urticaria
Clinical narrative: Information has been received from a consumer concerning her 16 year old daughter with no pertinent medical history who on 21-JUN-2009 was vaccinated with the first dose of GARDASIL (dose, route and LOT# not reported). Concomitant therapy included ZYRTEC and ZANTAC. Four weeks after vaccination, the patient developed hives and her lips and mouth swelled up. The patient was taken to the emergency room. The consumer also reported that her daughter's physician did "bloodwork" and a skin biopsy (results not reported). The "bloodwork" showed that the patient was "allergic to everything now". At the time of the report, the patient had not recovered. No further information is available.
Age: 20.0
Sex: F
Vaccine: HPV4
Symptoms: Injection site erythema, Injection site mass, Injection site pruritus, Injection site swelling
Clinical narrative: Information has been received from a registered nurse concerning a 20 year old female patient with allergy to kiwi unspecified reaction to a topical MYCOSTATIN as a child who on 10-SEP-2009 was vaccinated intramuscular with the first dose of 0.5 ml of GARDASIL (lot # 358271/0558X). Concomitant therapy included "birth control pills". 5 days after vaccination on 15-SEP-2009 the patient experienced a bump at the injection site as big as a half dollar. Around the bump was redness, itchiness and swelling about the size of a woman's hand. The patient did not have any reactions to vaccines as a child. The patient was told to put ice on the area and take BENADRYL and MOTRIN as needed. No laboratory diagnostics study was performed. The patient had sought medical attention by phone. At the time of report, the outcomes of the events were not reported. Additional information has been requested.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Dizziness, Injection site reaction, Injection site swelling, Migraine, Nausea
Clinical narrative: Information has been received from a nurse concerning her 15 year old daughter who in March 2008 was vaccinated with a first 0.5 ml dose of GARDASIL (Lot number not provided). In March 2008, the patient experienced dizziness, nausea, migraine and injection site reaction like swelling "which is size of silver dollar" after getting her dose of GARDASIL. The nurse also reported that the patient will not be getting any further doses of GARDASIL. The patient sought unspecified medical attention. No laboratory diagnostic studies were performed. On an unknown date the patient recovered from all symptoms. Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Blood glucose increased, Type 2 diabetes mellitus
Clinical narrative: Information has been received from a physician concerning a 21 year old female patient with no pertinent medical history reported who on 20-NOV-2006, 29-JAN-2007 and on 24-MAY-2007 was vaccinated with the first, second and third 0.5 mL doses of GARDASIL intramuscularly, respectively. It was reported that on 23-MAY-2008 the patient was diagnosed with type 2 diabetes (with increased glucose levels). The patient sought medical attention with an office visit. It was reported that the patient was originally started on metformin (manufacturer unspecified). It was reported that the patient was on insulin pump. The patient had not recovered at the time of the report. Additional information has been requested.
Age: 22.0
Sex: F
Vaccine: HPV4
Symptoms: Nausea, Vomiting
Clinical narrative: Information has been received from a 22 year old female Healthcare worker who on unspecified day was vaccinated with a first 0.5 ml dose of GARDISIL (Lot # was not provided). The patient reported that after she received the vaccine, in the same evening she experienced nausea and vomiting. The patient sought unspecified medical attention. At the time of the report, the patient recovered on an unspecified date. No further information is available.
Age: 28.0
Sex: F
Vaccine: HPV4
Symptoms: Human papilloma virus test positive, Papilloma viral infection, Smear cervix abnormal
Clinical narrative: Information has been received from a physician concerning a 28 year old female patient who 2 years ago approximately in September 2007, completed series of GARDASIL. Subsequently the patient was tested positive for Papanicolaou test for high risk human papillomavirus. Lot number was not available. The patient had sought physician for medical attention. It was unknown the outcome of the event at the time of reporting. Additional information has been requested.
Age: 22.0
Sex: F
Vaccine: HPV4
Symptoms: Hypoaesthesia, Nausea, Vomiting
Clinical narrative: Information has been received from a nurse concerning a 22 year old female patient with a history of hypothyroidism, migraine and neurocardiogenic syncope and with no drug reactions/allergies who in August 2009 was vaccinated IM with the fires 0.5 ml dose of GARDASIL vaccine. Concomitant therapies included SYNTHROID and MAXALT. Subsequently the patient experienced nausea, vomiting and numbness of the right arm post vaccination. The patient had sought unknown medical attention. There were no lab diagnostic studies performed. At the time of report the patient's status was recovered. Additional information has been requested.
Age: 26.0
Sex: F
Vaccine: HPV4
Symptoms: Asthenia, Burning sensation, Chest discomfort, Chest pain, Headache
Clinical narrative: Information has been received from a nurse practitioner concerning a female patient with migraine with aura who on 11-SEP-2009, was vaccinated with the first dose of GARDASIL. The nurse stated that on 14-SEP-2009, the patient reported weakness throughout her body after receiving her first dose of HPV vaccine. On 02-OCT-2009, the patient reported a headache which had lasted a week as well as tightness in her chest under her left breast and pain reaching to her scalp. On 04-OCT-2009, the patient reported tightness in her chest and a burning sensation in her scalp. On 05-OCT-2009, the patient reported occasional chest pain. At the time of the report, the patient had not recovered. The patient sought unspecified medical attention. Follow-up information was received from the nurse practitioner who reported that the 26 year old female patient with seasonal allergies and no known drug allergies was vaccinated on 11-SEP-2009 with the dose of GARDASIL (lot#0250X). No other vaccines were given on the same date. Concomitant therapy included ZYRTEC. The nurse reported that the events were not disabling and did not require treatment. At the time of the report, the patient's present status was unknown. Follow up information was received from the nurse practitioner who reported that the patient was vaccinated with a dose of GARDASIL intramuscularly into the left deltoid. On 11-SEP-2009, the day the patient received the GARDASIL she experienced weakness which continued for two days. She felt better on 14-SEP-2009. On 05-OCT-2009 the patient experienced headache for one week. On an unknown date the patient experienced burning in her chest muscles. At the time of this report, the outcome of the patient was unknown. Follow up information has been received from the nurse practitioner who indicated that the patient had migraines at the time of vaccination and her outcome was unknown. No further information is available.
Age: 24.0
Sex: F
Vaccine: HPV4
Symptoms: Chills, Injection site pain, Oral herpes, Pyrexia
Clinical narrative: Information has been received from a healthcare student concerning herself with no pertinent medical history and no drug reactions/allergies who in March 2009 was vaccinated IM with the first 0.5 ml dose of GARDASIL. There was no concomitant medication. On the same day the patient developed a "high fever", chills, a cold sore and arm pain at the injection site. About five days after receiving the first dose of GARDASIL the patient recovered. The patient had sought medical attention, phone call. There were no lab diagnostic tests performed. The patient received her second dose of GARDASIL in June 2009 with no adverse experience. Additional information has been requested.
Age: 22.0
Sex: F
Vaccine: HPV4
Symptoms: Pyrexia
Clinical narrative: Information has been received from a physician concerning  a 22 year old female patient who on 05-OCT-2009 was vaccinated with the third 0.5 ml dose of GARDASIL. There was no concomitant medication. On 05-OCT-2009 the patient had a fever for over 24 hours. There was no information provided on first and second dose. There was no lot number provided. The patient had sought unknown medical attention. At the time of report the patient's status was not recovered. Additional information has been requested.
Age: 14.0
Sex: F
Vaccine: HPV4
Symptoms: Human papilloma virus test positive, Papilloma viral infection, Smear cervix abnormal
Clinical narrative: Information has been received from a consumer concerning her 16 year old daughter with no known drug allergies who on 11-MAY-2007, 06-AUG-2007 and 13-NOV-2007 was vaccinated with the first, second and third doses of GARDASIL (lot# not reported). Mother reported that in "April 2008", the patient became pregnant and delivered a normal baby in "December 2008". Mother reported that "2 weeks ago" approximately on 22-SEP-2009 during a regular Pap smear checkup, the patient was tested positive for HPV (strain type unspecified). Mother noted that the patient was not hospitalized when the patient was tested positive for HPV but mother did not specify if the patient was hospitalized when the patient delivered her baby. At the time of the report, the patient had not recovered. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Feeling abnormal, Malaise
Clinical narrative: Information has been received from a consumer concerning her daughter who on 03-MAY-2007, 10-JUL-2007 and 15-NOV-2007 was vaccinated with first, second and third dose, respectively of GARDASIL (dose, route and lot numbers not reported). The consumer reported that her daughter was sick just about the entire freshman year at college. "She was not herself". It was noted that she did not display as severe symptoms as her sister (WAES 0910USA00170). It was not specified if the patient sought medical attention. This is one of two reports from the same source. Additional information has been requested.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: No reaction on previous exposure to drug, Urticaria
Clinical narrative: Information has been received from a registered nurse concerning a 15 year old female with seafood allergy, no known drug allergies and no pertinent medical history who on 22-SEP-2009 was vaccinated intramuscularly into left arm with the second 0.5mL dose of GARDASIL (LOT# 658271/0558X). The patient did not have a reaction after the first dose of GARDASIL which was given on 23-JUL-2009. On 23-SEP-2009, the patient's mother reported (via a phone message) that her daughter had hives. The patient sought an unspecified medical attention. The patient was not recovered at this time of the report. Additional information has been requested.
Age: 26.0
Sex: F
Vaccine: HPV4
Symptoms: Rash generalised
Clinical narrative: Information has been received from a physician concerning a 26 year old female patient with no relevant medical  history, no relevant past drug history and no known drug allergies who on 21-SEP-2009 was vaccinated with once unknown dose of GARDASIL (route and lot# not reported). There was no relevant concomitant medication. On 28-SEP-2009 the patient developed a generalized rash which was raised. The rash did not itch. It was unknown if there was any relevant laboratory data. As of 03-OCT-2009, it was unknown if there was any relevant laboratory data. As of 03-OCT-2009, it was unknown if the patient would continue to take GARDASIL and she continued to experience generalized rash. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Menorrhagia
Clinical narrative: Information has been received from a physician concerning a female patient who on an unspecified date was vaccinated with the first dose of GARDASIL (lot number not provided). Subsequently the patient began her menstrual period and did not stop bleeding for two months. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Parvovirus infection
Clinical narrative: Information has been received from an office manager concerning "a patient of theirs told her that her daughter was diagnosed with 'parvo' after receiving her third dose of GARDASIL, 0.5ml, IM". "Her (the patient) family has a history of lupus." The consumer is not a patient at this practice. The patient sought unspecified medical attention. At the time of the report, the patient's status was unknown. Additional information has been requested.
Age: 24.0
Sex: F
Vaccine: HPV4
Symptoms: Injection site mass, Myalgia, Oedema peripheral
Clinical narrative: Information has been received from a Nurse Practitioner concerning a 23 year old female who "approximately 11 day ago" on approximately 26-SEP-2009 was vaccinated with the second dose of GARDASIL (Lot number was not specified). The reporter mentioned that the patient experienced a lump at the injection site and muscle pain in her arm after vaccination. The patient did not seek medical attention. At the time of reporting the patient's outcome was unknown. Follow-up information was received from a certified nurse midwife who stated that a 24 (previously reported as 23) year old female patient with allergy to morphine who on 25-SEP-2009 (previously reported as approximately 26-SEP-2009) received her second dose of GARDASIL (lot # 663453/0249Y). The reporter stated that the patient had swelling in her arm 10 days later on 05-OCT-2009. It was mentioned that patient told to follow up with her family Doctor. The reporter stated that the patient rested her arm. It was also reported that this was patient's second injection in the 3 injection series. The patient recovered from the swollen arm 15 days later on 19-OCT-2009. No further information is available.
Age: 12.0
Sex: F
Vaccine: HPV4
Symptoms: Abnormal dreams, Anxiety, Dizziness, Dry mouth, Fatigue
Clinical narrative: Information has been received from a nurse practitioner concerning a 12 year old female patient with juvenile diabetes "not well under control" who on 30-AUG-2009 was vaccinated intramuscularly with her 0.5 ml second dose of GARDASIL. Concomitant therapy included FLUMIST received on 16-SEP-2009. According to the reporter, on 26-SEP-2009 the patient experienced acute anxiety, started feeling dizzy, scared, nervous, extremely tired, had bad dreams and also experienced auditory hallucinations and dry mouth. The nurse thought she had symptoms of a psychotic breakdown. The nurse also stated that the patient was first taken to the pharmacist who informed the patient's guardian that it was caused by GARDASIL. It was also reported that the patient started her first menstrual cycle on 16-SEP-2009. Therapy with GARDASIL was discontinued. No diagnostic tests were performed. The patient sought medical attention by an office visit. Additional information has been requested.
Age: 12.0
Sex: F
Vaccine: HPV4
Symptoms: Fear, Hallucination, auditory, Nervousness
Clinical narrative: Information has been received from a nurse practitioner concerning a 12 year old female patient with juvenile diabetes "not well under control" who on 30-AUG-2009 was vaccinated intramuscularly with her 0.5 ml second dose of GARDASIL. Concomitant therapy included FLUMIST received on 16-SEP-2009. According to the reporter, on 26-SEP-2009 the patient experienced acute anxiety, started feeling dizzy, scared, nervous, extremely tired, had bad dreams and also experienced auditory hallucinations and dry mouth. The nurse thought she had symptoms of a psychotic breakdown. The nurse also stated that the patient was first taken to the pharmacist who informed the patient's guardian that it was caused by GARDASIL. It was also reported that the patient started her first menstrual cycle on 16-SEP-2009. Therapy with GARDASIL was discontinued. No diagnostic tests were performed. The patient sought medical attention by an office visit. Additional information has been requested.
Age: 13.0
Sex: F
Vaccine: HPV4
Symptoms: Head injury, Reaction to previous exposure to any vaccine, Syncope
Clinical narrative: Information has been received from a physician concerning a 13 year old female patient who fainted after receiving a dose of GARDASIL intramuscularly. The patient wanted to leave the office but the office staff had the patient return to the office while they monitored her blood pressure and other vitals. The Physician indicated that the patient bumped her head when she fainted in their lobby. The patient told the physician that she was not hurt from bumping her head. The physician also reported that this patient had a history of fainting with prior immunization but the physician did not know this information at the time. The patient sought unspecified medical attention. On an unspecified date the patient recovered. Follow up information was received from a physician reporting that the 13 year old female student with no medical history or concurrent condition was vaccinated in the left deltoid with the first dose of GARDASIL (lot# 662300/0100Y) on 02-SEP-2009. There were no illnesses at the time of vaccination. Subsequently the patient experienced syncopal episode. The patient denied hitting her head-fell onto buttocks. Her vitals were stable. The patient recovered on 02-SEP-2009. No relevant diagnostic tests or laboratory data was collected. No further information is available.
Age: 24.0
Sex: F
Vaccine: HPV4
Symptoms: Alopecia, Blood test
Clinical narrative: Information has been received from a 24 year old female patient who was vaccinated with a complete series of GARDASIL (lot # not reported). The first dose was received in April 2007, the second dose in July 2007 and the third dose in October 2007. Concomitant therapy included birth control pills (unspecified). In approximately September ("Fall of 2007"), the patient started to notice that she had been losing hair more than normal and it had gotten worse recently. At the time of the report the patient's adverse experience had not improved and the patient had not recovered. Blood work was conducted by an endocrinologist. Additional information has been requested.
Age: 11.0
Sex: F
Vaccine: HPV4, TDAP
Symptoms: Activities of daily living impaired, Erythema, Injected limb mobility decreased, Pain in extremity, Pyrexia
Clinical narrative: Information has been received from a consumer concerning a neighbor's daughter a 11 year old female who on 05-OCT-2009 was vaccinated with GARDASIL (dose, route and lot number not reported). The consumer reported that the patient was experiencing redness, pain and lack of mobility in the vaccinated arm. The patient was also running a slight fever and she was crying from the pain and out of school. At the time of the report the outcome was not recovered. The patient did not sought medical attention. Follow-up information has been received from a nurse concerning the patient. It was reported that the patient never reported this adverse events to the office. The nurse also stated that the adverse events had nothing to do with GARDASIL, but it was a reaction to ADACEL. The vaccines were given in opposite arms and the patient had a reaction in the arm that received ADACEL. The morning of 03-NOV-2009, the nurse called the patient's mother who stated that the patient had recovered. No further information is available.
Age: 11.0
Sex: F
Vaccine: HPV4, TDAP
Symptoms: Vaccination complication
Clinical narrative: Information has been received from a consumer concerning a neighbor's daughter a 11 year old female who on 05-OCT-2009 was vaccinated with GARDASIL (dose, route and lot number not reported). The consumer reported that the patient was experiencing redness, pain and lack of mobility in the vaccinated arm. The patient was also running a slight fever and she was crying from the pain and out of school. At the time of the report the outcome was not recovered. The patient did not sought medical attention. Follow-up information has been received from a nurse concerning the patient. It was reported that the patient never reported this adverse events to the office. The nurse also stated that the adverse events had nothing to do with GARDASIL, but it was a reaction to ADACEL. The vaccines were given in opposite arms and the patient had a reaction in the arm that received ADACEL. The morning of 03-NOV-2009, the nurse called the patient's mother who stated that the patient had recovered. No further information is available.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Injection site reaction
Clinical narrative: Information has been received from a consumer concerning her 15 year old daughter who in July 2009, was vaccinated with a dose of GARDASIL (lot number not reported). Subsequently the patient experienced an injection site reaction after vaccination. Therapy with GARDASIL was discontinued. The symptom was improved. It was unknown if medical attention was sought. At the time of the report, the outcome of the patient was not reported. No further information is available.
Age: 19.0
Sex: F
Vaccine: HPV4
Symptoms: Cough, Ear pain, Oropharyngeal pain, Rhinorrhoea
Clinical narrative: Information has been received from a 19 year old female patient with no pertinent medical history and allergic to ZANTAC who on 05-OCT-2009, at 10:00 am was vaccinated IM with the first 0.5 ml dose of GARDASIL (lot number not reported). Concomitant therapy included daily birth control (unspecified). Later the same day, the patient had a runny nose and within 36 hours of the vaccination, on 06-OCT-2009, the patient developed "a cough, an earache and a sore throat". Unspecified medical attention was sought. There were no lab studies performed. The symptoms improved after the therapy was stopped. At the time of the report, the patient was recovering. Additional information has been requested.
Age: 11.0
Sex: F
Vaccine: HPV4
Symptoms: Nuclear magnetic resonance imaging normal, Swelling
Clinical narrative: Information has been received from an Optometrist concerning an approximately 11 year old female patient with no known drug reactions/allergies or pertinent medical history who "about 2-3 weeks ago", on approximately 17-SEP-2009, was vaccinated with her second dose of GARDASIL. There was no concomitant medication. The Optometrist reported that on an unspecified date during the examination she observed the patient optic nerve swelling. A recent magnetic resonance imaging was negative. It was noted that the patient was seen due to a request of contact lenses. During the examination the Optometrist observed the optic nerve swelling. The patient had not received any treatment for the optic nerve swelling. At the time of the report the patient had not had any symptoms and her vision had not been impaired in any way but the optic nerve swelling persisted. The Optometrist did not know the cause of the swelling and would continue to monitor the patient. The Optometrist contacted during telephone follow-up could not supply the following information: dates of vaccination and lot numbers. Additional information has been requested.
Age: 11.0
Sex: F
Vaccine: HPV4
Symptoms: Arthralgia, Myalgia
Clinical narrative: Information has been received from a consumer concerning her 11 year old granddaughter with no pertinent medical history who on an unknown date was vaccinated with a first dose of GARDASIL. On approximately 17-SEP-2009, "about 3 or 4 weeks ago", the patient started experiencing muscle and joint pain in her knees. The patient did not seek medical attention. At the time of the report, the patient's outcome was not recovered. No further information is available.
Sex: F
Vaccine: HPV4
Symptoms: Upper respiratory tract infection
Clinical narrative: Information has been received from a registered nurse concerning a female patient who on 08-DEC-2008 was vaccinated with the first dose of GARDASIL. On 24-MAR-2009 the patient received her second dose of GARDASIL and on 08-OCT-2009, when she was going to receive her third dose the patient developed an upper respiratory infection. So her third dose of GARDASIL was held. At the time of reporting the patient's status was unknown. Additional information has been requested.
Age: 14.0
Sex: F
Vaccine: HPV4
Symptoms: Burning sensation, Pruritus, Tuberculin test, Vaccination complication
Clinical narrative: Information has been received from a physician concerning a 14 year old female patient who on 10-APR-2009 was vaccinated with the first dose of GARDASIL in the left deltoid. The patient also received a PPD test the same day. Subsequently, the patient experienced burning feet and hands after the vaccination with GARDASIL. The experience was not immediate, but once she got home, for the next 48 hours, the patient had to have her hands and feet in buckets of ice water. She had sensation of burning. There was no swelling and there was no emergency room (ER) visit. It was reported that it seemed to have a spontaneous onset and a spontaneous recovery. There was no preventive of serious criteria needed. The doctor determined that the patient was allergic to GARDASIL and would not administer any more doses. At the time of the report, the patient recovered on an unspecified date. It was noted that the patient was also on ADDERALL, but was on ADDERALL holiday because of spring break. Follow-up information has been received from a physician concerning a 14 year old female patient with no illness at time of vaccination and with no pre-existing allergies who on 10-APR-2009 at 3:00 PM was vaccinated with the first dose of GARDASIL IM in the left deltoid. At 8:00 PM on 10-APR-2009 the patient experienced burning and itching of feet and hands to the point of putting them in ice water. The events lasted for 2 days. Medical attention was not sought. No laboratory diagnostic test was taken. On 12-APR-2009, the patient recovered. The reporting physician felt that burning and itching of feet and hands and allergy to GARDASIL were related to therapy with GARDASIL. Additional information is not expected.
Age: 20.0
Sex: F
Vaccine: HPV4
Symptoms: Dizziness, Syncope
Clinical narrative: Information has been received from a certified medical assistant concerning a 20 year old female patient with reactive airways disease and no known drug/allergies who on 10-AUG-2009 and 09-OCT-2009 was vaccinated IM with the first and second doses of GARDASIL (lot # 0670Y). Concomitant therapy included oral hormonal contraceptives (unspecified) and unspecified inhaler. On 09-OCT-2009, the patient fainted in the physician's office after receiving her second dose of vaccine. There were no laboratory diagnostic studies performed. At the time of the report, the patient was recovering. Follow-up information has been received from a health professional concerning a 20 year old female patient with a history of fainting who on 09-OCT-2009 was vaccinated with the second doses of GARDASIL (lot# 0670Y) in the right gluteus. After the vaccination, the patient said she felt like she was going to pass out. The reporter said that as she looked up, she saw the patient go down. They all got the patient up in a wheelchair and called her mother. When waiting for the mother, they gave the patient a bagel and some orange juice. The patient said she hadn't had anything to eat yet. When her mother got there, they were advised to go to the emergency room (ER) for follow up. Medical attention was not sought. Additional information has been requested.
Age: 27.0
Sex: F
Vaccine: HPV4
Symptoms: Rash generalised
Clinical narrative: Information has been received from a medical assistant concerning a 26 year old female patient with sulfonamide allergy and no pertinent medical history who on 18-MAY-2009 and 20-JUL-2009 was vaccinated IM with the first 0.5ml (lot# 1702X) and second 0.5ml (lot # unknown) doses of GARDASIL. There was no concomitant medication. On 21-JUL-2009 the patient developed a "rash all over her body" after administration of her second dose. The patient contacted the physician by phone. There were no laboratory diagnostic studies performed. On 25-JUL-2009, the patient recovered. Follow-up information has been received from a medical assistant concerning a 27 year old female patient who on 18-MAY-2009 was vaccinated with the first dose of GARDASIL (lot# 1702X). On 20-JUL-2009, the patient was vaccinated with the second dose of GARDASIL IM into the deltoid. In July 2009 (also reported as 21-JUL-2009 previously), the patient developed a rash. At the time of the report, the patient recovered. Additional information is not expected.
Age: 21.0
Sex: F
Vaccine: HPV4
Symptoms: Immediate post-injection reaction, Syncope, Vomiting
Clinical narrative: Information has been received from a physician concerning a 21 year old female patient who on an unspecified date was vaccinated with a dose of GARDASIL.  It was reported that the patient fainted immediately after receiving GARDASIL vaccine, she woke up shortly after.  It was reported that shortly after she woke up she vomited at least once, but perhaps two times.  The doctor kept the patient in her office for over an hour and after that she was ok to leave.  It was reported that GARDASIL was the only vaccine given at that time.  Additional information has been requested.